Dr Reddy's denied approval for Phase 3 trials of Sputnik Light vaccine
The central government's Subject Expert
Committee (SEC) has denied permission to Dr Reddy's Laboratories for conducting
Phase 3 trials of Russia's COVID-19 vaccine
Sputnik Light in India.
"The SEC has denied permission to Dr
Reddy's to conduct phase-3 trials on the Russian vaccine Sputnik
Light in India," sources told ANI here.
After launching Sputnik V, Russia had
introduced a new single-dose vaccine called Sputnik Light in May.
Sputnik Light has also been developed by
the Russian Ministry of Health, the Gamaleya National Research Centre of
Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF).
The RDIF had earlier said that the Russian
Sputnik Light coronavirus vaccine demonstrates 78.6 per cent to 83.7 per cent
efficacy among the elderly, according to real-world data collected by the Ministry
of Health of the Buenos Aires province (Argentina).
According to the data from over 186,000
people aged 60-79, more than 40,000 of whom received a shot of Sputnik Light
(first dose of Sputnik V) as part of the mass-scale civil vaccination program,
the infection rate between 21st and 40th day from the date of receiving the
first dose was only 0.446 per cent. Read
More
Comments
Post a Comment